Please login to the form below

Not currently logged in
Email:
Password:

Merck earmarks €35m for Italian biologics site development

Pharma firm plans new biotech production line at its Bari facility

Bari

Merck KgAa is set to invest €35m to expand its manufacturing site in the town of Modugno, Bari in Italy, to add a new production line for aseptic filing of biologics.

Expected to be fully operational by 2022, the new production line will support the growth of the company’s biotech medicines portfolio.

Stefan Oschmann, chairman of the executive board and CEO of Merck, said: “This investment underpins the importance of the Modugno-Bari production site for our growing healthcare business.”

Modugno is one of 15 manufacturing sites in operation by Merck and the facility currently employs around 225 people.

Oschmann added: “It will help us to secure the supply of medicines that improve people’s lives around the world.”

The new production line - which is expected to pump out 14 million units per year - will be used for biologic medicines for several disease areas including multiple sclerosis, fertility and endocrinology.

The move builds on a 2014 investment made by the pharma firm that saw it inject €50m into the site for a fully automated production line using isolator technology, as well as an automated warehouse.

Article by
Gemma Jones

10th October 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...

Infographics